Get a glimpse into our company and investor data—powered by the PitchBook Platform
Developer of a cancer therapy. The company develops immunotherapy for lungs and prostate cancer.
You’re viewing a free company profile from the PitchBook Platform. To explore T-Epivaccines’s full profile, request a free trial.
© 2019 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.